These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33637620)

  • 21. Transcriptomic Profiling of Control and Thyroid-Associated Orbitopathy (TAO) Orbital Fat and TAO Orbital Fibroblasts Undergoing Adipogenesis.
    Kim DW; Taneja K; Hoang T; Santiago CP; McCulley TJ; Merbs SL; Mahoney NR; Blackshaw S; Rajaii F
    Invest Ophthalmol Vis Sci; 2021 Jul; 62(9):24. PubMed ID: 34269815
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Role of the Immune Response in the Pathogenesis of Thyroid Eye Disease: A Reassessment.
    Rosenbaum JT; Choi D; Wong A; Wilson DJ; Grossniklaus HE; Harrington CA; Dailey RA; Ng JD; Steele EA; Czyz CN; Foster JA; Tse D; Alabiad C; Dubovy S; Parekh PK; Harris GJ; Kazim M; Patel PJ; White VA; Dolman PJ; Edward DP; Alkatan HM; Al Hussain H; Selva D; Yeatts RP; Korn BS; Kikkawa DO; Stauffer P; Planck SR
    PLoS One; 2015; 10(9):e0137654. PubMed ID: 26371757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyaluronic acid induces COX-2 expression via CD44 in orbital fibroblasts from patients with thyroid-associated ophthalmopathy.
    Lim HS; Back KO; Kim HJ; Choi YH; Park YM; Kook KH
    Invest Ophthalmol Vis Sci; 2014 Oct; 55(11):7441-50. PubMed ID: 25342622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential role of IGF-1R in the interaction between orbital fibroblasts and B lymphocytes: an implication for B lymphocyte depletion in the active inflammatory phase of thyroid-associated ophthalmopathy.
    Wang R; Song D; Zhong Y; Li H
    BMC Immunol; 2024 May; 25(1):31. PubMed ID: 38734625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiologic imaging shows variable accuracy in diagnosing orbital inflammatory disease and assessing its activity.
    Lee MJ; Hamilton BE; Pettersson D; Ogle K; Murdock J; Dailey RA; Ng JD; Steele EA; Verma R; Planck SR; Martin TM; Choi D; Rosenbaum JT
    Sci Rep; 2020 Dec; 10(1):21875. PubMed ID: 33318556
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergy between an IGF-1R antibody and Raf/MEK/ERK and PI3K/Akt/mTOR pathway inhibitors in suppressing IGF-1R-mediated growth in hematopoietic cells.
    Bertrand FE; Steelman LS; Chappell WH; Abrams SL; Shelton JG; White ER; Ludwig DL; McCubrey JA
    Leukemia; 2006 Jul; 20(7):1254-60. PubMed ID: 16642049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Palmitate induced secretion of IL-6 and MCP-1 in orbital fibroblasts derived from patients with thyroid-associated ophthalmopathy.
    Paik JS; Cho WK; Oh EH; Lee SB; Yang SW
    Mol Vis; 2012; 18():1467-77. PubMed ID: 22736938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel role of SF1 in alleviating thyroid-associated ophthalmopathy through the AMPK/mTOR signaling pathway.
    Wang XX; Wang XX; Jia XF; Guo T; Xian TZ; Liu L; Xu ZJ; Guo Y; Deng X; Zhang LN; Man FL; Zhang XB; Chen T; Pan Q; Guo LX
    Gene; 2019 Apr; 691():132-140. PubMed ID: 30562606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chitosan inhibits inflammation and adipogenesis of orbital fibroblasts in Graves ophthalmopathy.
    Xiong H; Wu M; Zou H; Jiang S; Yi H; Yi T; Wang Q; Liu D; Zhou Y; Wei C; Zhou X
    Mol Vis; 2018; 24():509-517. PubMed ID: 30090014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MiR-143 Targets IGF-1R to Suppress Autoimmunity in Thyroid-Associated Ophthalmopathy.
    Tang W; Lv Q; Huang X; Li Y; Zou J; Zheng J; Sun L; Bao Y; Chen H; Li T; Zhang B; Xue S; Song Y; Zhang X; Chen X; Cai J; Shi Y
    J Inflamm Res; 2022; 15():1543-1554. PubMed ID: 35256853
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effects of LPS-induced inflammation on differentiation of orbital pre-adipocytes in thyroid-associated ophthalmopathy].
    Yi WS; Xu XL
    Zhonghua Yan Ke Za Zhi; 2011 Feb; 47(2):156-61. PubMed ID: 21426847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibitory Effect of Idelalisib, a Selective Phosphatidylinositol 3-Kinase δ Inhibitor, on Adipogenesis in an In Vitro Model of Graves' Orbitopathy.
    Ko J; Kim JY; Lee EJ; Yoon JS
    Invest Ophthalmol Vis Sci; 2018 Sep; 59(11):4477-4485. PubMed ID: 30193323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differentially expressed circular RNAs in orbital adipose/connective tissue from patients with thyroid-associated ophthalmopathy.
    Wu L; Zhou R; Diao J; Chen X; Huang J; Xu K; Ling L; Xia W; Liang Y; Liu G; Sun X; Qin B; Zhao C
    Exp Eye Res; 2020 Jul; 196():108036. PubMed ID: 32376473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin-like growth factor-1 receptor-mediated inhibition of A-type K(+) current induces sensory neuronal hyperexcitability through the phosphatidylinositol 3-kinase and extracellular signal-regulated kinase 1/2 pathways, independently of Akt.
    Wang H; Qin J; Gong S; Feng B; Zhang Y; Tao J
    Endocrinology; 2014 Jan; 155(1):168-79. PubMed ID: 24080365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insights Into Local Orbital Immunity: Evidence for the Involvement of the Th17 Cell Pathway in Thyroid-Associated Ophthalmopathy.
    Fang S; Huang Y; Wang N; Zhang S; Zhong S; Li Y; Sun J; Liu X; Wang Y; Gu P; Li B; Zhou H; Fan X
    J Clin Endocrinol Metab; 2019 May; 104(5):1697-1711. PubMed ID: 30517642
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of 11beta-hydroxysteroid dehydrogenase 1 in adipogenesis in thyroid-associated ophthalmopathy.
    Tomlinson JW; Durrani OM; Bujalska IJ; Gathercole LL; Tomlins PJ; Reuser TT; Rose GE; Curnow SJ; Stewart PM; Walker EA; Rauz S
    J Clin Endocrinol Metab; 2010 Jan; 95(1):398-406. PubMed ID: 19880789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of insulin-like growth factor-1 (IGF-1) pathway in the pathogenesis of Graves' orbitopathy.
    Smith TJ; Hegedüs L; Douglas RS
    Best Pract Res Clin Endocrinol Metab; 2012 Jun; 26(3):291-302. PubMed ID: 22632366
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synergy between PI3K/Akt and Raf/MEK/ERK pathways in IGF-1R mediated cell cycle progression and prevention of apoptosis in hematopoietic cells.
    Shelton JG; Steelman LS; White ER; McCubrey JA
    Cell Cycle; 2004 Mar; 3(3):372-9. PubMed ID: 14726697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IL-17A Promotes RANTES Expression, But Not IL-16, in Orbital Fibroblasts Via CD40-CD40L Combination in Thyroid-Associated Ophthalmopathy.
    Fang S; Huang Y; Zhong S; Zhang Y; Liu X; Wang Y; Gu P; Zhou H; Fan X
    Invest Ophthalmol Vis Sci; 2016 Nov; 57(14):6123-6133. PubMed ID: 27832278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lymphoma and inflammatory disorders presenting in the orbit- a comparison of characteristics from a 10-year series in a tertiary hospital.
    Hunt S; Pereni I; Ford R; Garrott H
    Orbit; 2022 Jun; 41(3):315-320. PubMed ID: 33645420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.